Philip Rosenthal

Papers

Total Citations

296

H-Index

About

Philip Rosenthal is a leading figure in antiparasitic drug discovery, with a career focused on the molecular mechanisms of parasitic diseases and the development of novel therapeutics. His research centers on cysteine proteases—enzymes critical for virulence in parasites like those causing malaria and leishmaniasis. Rosenthal’s major contribution lies in elucidating the structural basis for drug design, most notably through his highly cited 2009 study on vinyl sulfones as antiparasitic agents, which has garnered 296 citations. This work provided a blueprint for targeting papain-family cysteine proteases, demonstrating how crystal structures can guide the rational design of potent inhibitors. Beyond this landmark paper, Rosenthal’s research has profoundly impacted the field, advancing our understanding of protease function in parasite biology and paving the way for clinical candidates. His achievements include pioneering studies on antimalarial drug resistance and the development of protease inhibitors that have entered preclinical trials. With a citation record reflecting his influence, Rosenthal’s work continues to inspire new strategies for combating neglected tropical diseases, making him a pivotal figure in global health research.